ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.

Dorbala, Sharmila;Ando, Yukio;Bokhari, Sabahat;Dispenzieri, Angela;Bourque, Jamieson M;et.al.
(2021) Circulation. Cardiovascular Imaging — Vol. 14, n° 7, p. e000030 [1-10] (2021)

Files

2021_Dorbala_Circ_Cardiovasc_Imaging_e000030.pdf
  • Open Access
  • Adobe PDF
  • 246.78 KB

Details

Authors
  • Dorbala, Sharmila
    Author
  • Ando, Yukio
    Author
  • Bokhari, Sabahat
    Author
  • Dispenzieri, Angela
    Author
  • Author
  • Bourque, Jamieson M
    Author
Show more
Abstract
Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.
Affiliations
  • UZ LeuvenDepartment of Nuclear Medicine

Citations

Dorbala, S., Ando, Y., Bokhari, S., Dispenzieri, A., Falk, R. H., Ferrari, V. A., Fontana, M., Gheysens, O., Gillmore, J. D., Glaudemans, A. W. J. M., Hanna, M. A., Hazenberg, B. P. C., Kristen, A. V., Kwong, R. Y., Maurer, M. S., Merlini, G., Miller, E. J., Moon, J. C., Murthy, V. L., et al. (2021). ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. Circulation. Cardiovascular Imaging, 14(7), e000030 [1-10]. https://doi.org/10.1161/HCI.0000000000000030 (Original work published 2021)